SCHEMBL11903039

SCHEMBL11903039

Clc1ccc(-c2cc(N3CCCOCC3)sc2-c2nnc[nH]2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
AR P10275 1/20 0.42
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
CNR2 P34972 3/20 0.36
PRKDC P78527 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
ALPL P05186 1/20 0.35
CRHR1 P34998 1/20 0.35
DPP4 P27487 1/20 0.35
MAOA P21397 1/20 0.34
MAPT P10636 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11902997 0.97 RAB9A (0.44) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL11903299 0.88 ESR1 (0.38) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL11903172 0.87 PRKDC (0.37) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL11903062 0.84 PRKDC (0.40) RAB9ANPC1PIK3CAMTORPRKDC
SCHEMBL6748729 0.79 PIK3CA (0.68) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL1551709 0.79 RAB9A (0.50) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL11902424 0.79 CRHR1 (0.46) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL6726829 0.79 PIK3CA (0.51) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL1552141 0.76 PIK3CA (0.71) RAB9ANPC1ARPIK3CAMTOR
SCHEMBL6726845 0.75 PIK3CA (0.53) RAB9ANPC1ARPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440664-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-05-14 US disclosed
US-20120202812-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202812-A1 HETEROARYLS AND USES THEREOF PIK3R3, AKT1S1, PIK3R1 RAB9A 2320/4885NPC1 3121/4885AR 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.